Clinical Trials Directory

Trials / Completed

CompletedNCT04168879

Sphenopalatine Ganglion Block for Nasal Surery

Efficacy of Suprazygomatic Approach of Sphenopalatine Ganglion Block for Nasal Surery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

nasal surgery carries many perioperative challenges, intraoperative bleeing and its effect on surgical field i the main intraoperative concern an postoperative agitation and its serious complications is the main postoperative challenge.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine 0.5% Preservative-Free Injectable Solution1.5 ml of Bupivacaine 0.5% Preservative-Free Injectable Solution used to block the sphenopalatine ganglion by ultrasound guided suprazygomatic approach
DRUGnormal saline1.5 ml of normal saline is delivered to the sphenopalatine ganglion by ultrasound guided suprazygomatic approach

Timeline

Start date
2021-11-10
Primary completion
2023-12-10
Completion
2023-12-10
First posted
2019-11-19
Last updated
2024-05-28

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04168879. Inclusion in this directory is not an endorsement.